...Thanks for joining us here at Piper Sandler's Annual Healthcare Conference. I'm Joe Catanzaro from Piper's biotech team. It's my pleasure to welcome Keros Therapeutics and their CEO, Jas Seehra. Jas, thanks so much for joining us. Obviously, probably a lot to get through in 25 minutes. I could probably ask you like one question on activin A, and that clock will beat the zero. But maybe to just start things off -- because there are a lot of things to get through -- could just sort of help level set the discussion, introduced Keros, what you guys are about? And then we'll jump into, I think, each specific program and data set that's expected at ASH. Jas Seehra ...